Sign in
HPR32 An Assessment of Breast Cancer Drug Innovation in the United States (1980-2021)
Journal article   Peer reviewed

HPR32 An Assessment of Breast Cancer Drug Innovation in the United States (1980-2021)

A Althomali, M Al ghamdi, E Althagafi and E Seoane-Vazquez
Value in health, Vol.25(7), p.S472
07/2022

Metrics

1 Record Views

Details